Dr. Joseph V. Lillis is a board-certified Dermatologist offering expertise in all areas of dermatology including skin cancer surveillance, medical dermatology, and Mohs Micrographic surgery. A graduate of Georgetown University Medical School, Dr. Lillis did his dermatology residency at Oregon Health & Science University in Portland, Oregon, where he served as Chief Resident during his final year.

He has since worked as an assistant clinical professor in the Division of Dermatology at The University of California San Diego Medical Center and in private practice at San Luis Dermatology & Laser Clinic in San Luis Obispo, California before returning home to Northern Colorado. He has published several articles in peer-reviewed medical journals, serves as a manuscript reviewer for the British Journal of Dermatology, and has spoken at national and regional dermatology conferences. He is a fellow of the American Academy of Dermatology, a member of the American Medical Association, and a member of the Colorado Dermatologic Society. In addition, he is board certified in Micrographic Dermatologic Surgery, is a fellow of the American Society for Mohs Surgery, and has performed over 12,000 Mohs cases in the past 15 years.

Raised in Loveland, Dr. Lillis returned home to Northern Colorado in June of 2014 and founded Colorado Dermatology Group with Dr. Brooke Caufield in 2016.

When not at work, his favorite days are those spent traveling and hiking with his wife and two children, playing tennis on his local USTA team, skiing with old high school friends, and gathering to celebrate birthdays and holidays with his large extended family.

Education:
BA: University of Notre Dame (1997-2001), Theology/Pre-professional Studies
MD: Georgetown University School of Medicine (2001-2005)
Internship: Legacy Health System, Portland Oregon (2005-2006), Internal Medicine
Residency:Oregon Health & Science University (2006-2009), Dermatology; Chief Resident: 2009

Specific areas of specialization:
Medical and surgical management of complex skin cancer patients, psoriasis, contact dermatitis and hand eczema